ASH 2026 abstracts are out. It’s great to see major centres creating opportunities for early-career haematologists and researchers to present their work. This is exactly the culture we should be fostering.

What I find harder to understand is why very senior, established professors still need to take up oral presentation slots for abstracts. Surely these opportunities should be used to showcase and support the next generation of researchers?

🎧 A new podcast episode is now LIVE!

Hear two fantastic roundtable discussions from #iwMPN26, in which leading experts @RaajitRampal, @pankitvachhani, & Nikolai Podoltsev discuss promising combination strategies in frontline #myelofibrosis, and @harrisoncn1, @doctorpemm, @MDm& Rupali Bhave share updates on novel agents being explored in the second-line setting.

Click here to listen:
👉 ow.ly/qtjW5102nSb

#MPNsm #HemOnc #iwMDSMPN26

The people who make an impact for our MPN patients at MSK in attendance at Bklyn MPN Congress- bench and clinical researchers and clinicians. Never worked with a more outstanding group than this. Thanks @doctorpemm @MeltonMedEd et al. For organizing .@MSK_DeptOfMed @JeetayuB

Outstanding @MSKCancerCenter representation from the #mpnsm group at #MPNCongrees: researchers, fellows, CTNs, APPs, and MDs! @MSK_DeptOfMed @RaajitRampal

Proud to have contributed to newly published 2026 @ASH_hematology Guidelines for Myelofibrosis!
10 evidence-based recs spanning molecular testing, JAK inhibitors, anemia & transplant.

📄 doi.org/10.1182/blooda…

#Myelofibrosis #MPN #Hematology #ASHGuidelines #BloodAdvances

Join the Canadian MPN Network for its Annual Conference - MPN: Heart, Health, and Hope
- Cardiac Health In MPNs
- Complementary Therapies MPN-Fit Study & Nutrition
- Bone Marrow & Understanding BMB Results
Date Saturday, October 24, 2026
Time 12:30 PM EST
ow.ly/MSrC50ZWvYZ

@RaajitRampal Our commentary is in response to the TRANSFORT-1 ph3 study results. Please check that out too. @doctorpemm @MPN_RF @MPNVoice @MPN_Hub @uabmedicine @MSKCancerCenter

🚨Thrilled to share our latest commentary in @BloodJournal with @RaajitRampal! This is on the very pertinent topic of #myelofibrosis trial #endpoints. We discuss what ails our field, the history, and the possible future toward which we must work.

ashpublications.org/blood/article/…

Trying to make sense of the JAKi combination trials, I found this commentary for TRANSFORM-1 by @RaajitRampal and Pankit Vachhani full of great insight into clinical endpoints for MF treatments doi.org/10.1182/blood.…

If you want to get ahead, just be easy to work with. Show up on time. Do what you said you'd do. Bring solutions, not problems. Never create drama. Be responsive. Be emotionally consistent. Be kind. People will always want to support someone who just makes their life easier.

Great framing from Tanya Wroblewski (FDA) at #iwMDS & #iwMPN: strength of evidence is what separates surrogate endpoints.
✅ Validated: known to predict clinical benefit (BP ↓ → stroke ↓)
🔶 Reasonably likely surrogate: expected to predict benefit, the basis for accelerated appremOnc #iwMDSMPN26

One of the emergent joys of coming to meetings is the chance to reconnect with former mentees and learn how their careers and lives are blossoming. Same for old friends.
@TheElfLab @doctorpemm @GabyHobbs

Congratulations to the authors and the Progression Research Network on this publication. We are proud to see this collaborative effort contribute to the growing body of research focused on MPN disease progression.

Why do some pts with MPNs stay stable for decades while others progress? @MPN_RF launched the MPN Progression Research Network in 2020 to address this pressing issue. We now present a blueprint for dealing with progression from these efforts. (nature.com/articles/s4137…).A thread🧵

Our call to action:
✅ Integrate clinical, molecular and inflammatory markers
✅ Run prospective trials with long follow-up
✅ Standardize assays and endpoints
✅ Engage regulators early
✅ Bring patients into trial design

This is a heavy lift, but we have many hands, including patients and their families. @GabyHobbs @KuykendallMd @GhaithAbuZeinah @Anand_88_Patel @FlorianHeidel @RWinneker @DrJoeScandura @lauracmichaelis @LindaResar @oligo67 @MSKCancerCenter @mpn_consortium #MPNSM